Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 784
Ph III recruiting: 82
Growth YoY: +24.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06228404	Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC	active not recruiting	Early Phase 1	18	Shanghai Changzheng HospitalOTHER	1	Jul 23, 2026	clinicaltrials
NCT05477823	Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer	active not recruiting	Early Phase 1	30	University of Wisconsin, MadisonOTHER	1	Jun 2, 2026	clinicaltrials